Diabète
Articles
SFD 2024 : Flashback sur quelques séances marquantes
Diabète de type 1 : tous dans les starting blocks pour changer le cours de la maladie.
L'immunité au coeur des diabètes : un aspect central de la SFD 2024.
Focus sur la cellule beta / exploration de la pathogenèse du diabète.
The observational ORION study
Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan.
.png/jcr:content/jcr_content%20(9).png)
-svg.svg)
How Does Glycaemic Control Impact Complications in Type 2 Diabetes?
Summary of The UK Prospective Diabetes Study (UKPDS).
Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?
Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.
Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?
(Based on the study: Stratton IM, et al. BMJ. 2000;321(7258):405-12).
Autoimmune Type 1 Diabetes
The Type 1 Diabetes (T1D) field is evolving.
Recognition of the presymptomatic stages in T1D is growing.1-4
The clinical benefits of early detection of T1D are being highlighted.3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.1,2
.svg)
